DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, featuring promising improvements throughout various clinical and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA supplies a safer, additional trusted alternate for therapeutic use,